Over 700 million instances of COVID-19 have been identified globally, causing almost 7 million deaths over the years. Precise identification and reliable indicators of the severity of the illness, response to treatment, and prognosis are crucial for this large influx of patients seeking medical attention in hospitals and healthcare facilities. Laboratory tests that examine biomarkers provide crucial aid in this scenario.

These tests are vital for monitoring the patient's health throughout the course of the illness and are categorized by the disease progression over days. Whether the patient is receiving care at home or is admitted to a hospital, these tests are indispensable.